Navigation Links
Russian Government Allocate Funds for HIV Vaccine Project

The Russian government will allocate one billion rubles (US$39.4 million) to develop a vaccine for HIV, Russia's chief doctor has said.

"The government will soon issue a decree allocating one billion rubles to boost current research for a HIV vaccine," Gennady Onishchenko said Thursday.

He said four leading Russian research institutes would take part in the three-year project, including the Vector State Research Center of Virology and Biotechnology in Novosibirsk, and the Institute of Immunology in Moscow.

Russia plans to double the number of infected people receiving antiretroviral therapy and to increase the number of those being tested for the virus from 21.7 million to 22 million, Onishchenko said.

Since 1987 when the first HIV case was reported in Russia, 388,871 cases have been registered, and women infected with the virus have given birth to 1,200 children. Among the most infected areas are the Moscow, Irkutsk, Samara, Orenburg, and Leningrad Regions.


'"/>




Page: 1

Related medicine news :

1. SARS reaches Russian Federation
2. Admission to Russian varsities is looking up
3. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
4. Russians face the death trap laid by alcoholism
5. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
6. High Rates of Latent TB Infection Found in Russian Health Workers
7. Fire at Russian Nursing Home Kills 63
8. Russian Health Care Marred by Corruption
9. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
10. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
11. Tanzanian Government Sanctions $20 Million For AIDS Arug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: